These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20511185)

  • 1. Fatty acid synthase as a novel target for meningioma therapy.
    Haase D; Schmidl S; Ewald C; Kalff R; Huebner C; Firsching R; Keilhoff G; Evert M; Paulus W; Gutmann DH; Lal A; Mawrin C
    Neuro Oncol; 2010 Aug; 12(8):844-54. PubMed ID: 20511185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas.
    Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K
    Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid synthase is a predictive marker for aggressiveness in meningiomas.
    Makino K; Nakamura H; Hide T; Yano S; Kuroda J; Iyama K; Kuratsu J
    J Neurooncol; 2012 Sep; 109(2):399-404. PubMed ID: 22744755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
    Wang WQ; Zhao XY; Wang HY; Liang Y
    J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
    Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
    PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
    Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
    Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    Cancer; 2007 Feb; 109(3):588-97. PubMed ID: 17177201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase: a novel target for antiglioma therapy.
    Zhao W; Kridel S; Thorburn A; Kooshki M; Little J; Hebbar S; Robbins M
    Br J Cancer; 2006 Oct; 95(7):869-78. PubMed ID: 16969344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
    Ragel BT; Jensen RL; Gillespie DL; Prescott SM; Couldwell WT
    J Neurosurg; 2005 Sep; 103(3):508-17. PubMed ID: 16235684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
    Grube S; Dünisch P; Freitag D; Klausnitzer M; Sakr Y; Walter J; Kalff R; Ewald C
    J Neurooncol; 2014 Jun; 118(2):277-287. PubMed ID: 24789255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
    Hughes DT; Martel PM; Kinlaw WB; Eisenberg BL
    Cancer Invest; 2008 Mar; 26(2):118-27. PubMed ID: 18259941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
    Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
    Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
    Shiragami R; Murata S; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Koda K
    Int J Oncol; 2013 Aug; 43(2):431-8. PubMed ID: 23754252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.
    Kanno H; Nishihara H; Wang L; Yuzawa S; Kobayashi H; Tsuda M; Kimura T; Tanino M; Terasaka S; Tanaka S
    Neuro Oncol; 2013 Jul; 15(7):853-64. PubMed ID: 23539121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 expression is increased as a function of malignancy grade and negatively regulates cell growth in meningioma.
    Huang YC; Wei KC; Chang CN; Chen PY; Hsu PW; Chen CP; Lu CS; Wang HL; Gutmann DH; Yeh TH
    PLoS One; 2014; 9(9):e108228. PubMed ID: 25247996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
    Das A; Alshareef M; Henderson F; Martinez Santos JL; Vandergrift WA; Lindhorst SM; Varma AK; Infinger L; Patel SJ; Cachia D
    Clin Transl Oncol; 2020 Jul; 22(7):1138-1145. PubMed ID: 31732915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas.
    Johnson MD; O'Connell M; Vito F; Bakos RS
    J Neurooncol; 2009 Apr; 92(2):129-36. PubMed ID: 19034385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.